D

Diagnos Laboratorium Utama PT Tbk
IDX:DGNS

Watchlist Manager
Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
Watchlist
Price: 188 IDR 0.53% Market Closed
Market Cap: 235B IDR

Diagnos Laboratorium Utama PT Tbk
Cash & Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Diagnos Laboratorium Utama PT Tbk
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
D
Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
Cash & Cash Equivalents
Rp4.2B
CAGR 3-Years
-55%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Prodia Widyahusada Tbk PT
IDX:PRDA
Cash & Cash Equivalents
Rp591.7B
CAGR 3-Years
20%
CAGR 5-Years
38%
CAGR 10-Years
N/A
No Stocks Found

Diagnos Laboratorium Utama PT Tbk
Glance View

Market Cap
235B IDR
Industry
Health Care

PT Diagnos Laboratorium Utama Tbk engages in the provision of health support service. The company employs 54 full-time employees The company went IPO on 2021-01-15. The firm is engaged in providing health support services, such as health laboratories, other diagnostic drawing centers, blood testing laboratories, pharmaceutical warehouses, eye banks, sperm banks and blood banks, organ transplant banks, and other medical support services. The company operates through providing health services using laboratories segment. The Company’s products and services include clinical pathology laboratory, anatomy pathology laboratory, genomic laboratory, homecare health services, corporate health services, and Covid-19 checkup. The firm serves markets, such as Jakarta, Depok, Bali, Bandung, Bekasi, Padang, Makassar, Tangerang Selatan, Dumai, Batam, Purwakarta, Karawang, and Brebes. The company has branch offices in Ciputat (South Tangerang), Denpasar (Bali), Padang (West Sumatra), and Makassar, South Sulawesi.

DGNS Intrinsic Value
320.79 IDR
Undervaluation 41%
Intrinsic Value
Price
D

See Also

What is Diagnos Laboratorium Utama PT Tbk's Cash & Cash Equivalents?
Cash & Cash Equivalents
4.2B IDR

Based on the financial report for Dec 31, 2024, Diagnos Laboratorium Utama PT Tbk's Cash & Cash Equivalents amounts to 4.2B IDR.

What is Diagnos Laboratorium Utama PT Tbk's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
25%

Over the last year, the Cash & Cash Equivalents growth was -59%. The average annual Cash & Cash Equivalents growth rates for Diagnos Laboratorium Utama PT Tbk have been -55% over the past three years , 25% over the past five years .

Back to Top